BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bauer G, Elsallab M, Abou-El-Enein M. Concise Review: A Comprehensive Analysis of Reported Adverse Events in Patients Receiving Unproven Stem Cell-Based Interventions. Stem Cells Transl Med. 2018;7:676-685. [PMID: 30063299 DOI: 10.1002/sctm.17-0282] [Cited by in Crossref: 66] [Cited by in F6Publishing: 66] [Article Influence: 22.0] [Reference Citation Analysis]
Number Citing Articles
1 Ikonomou L, Wagner DE, Turner L, Weiss DJ. Translating Basic Research into Safe and Effective Cell-based Treatments for Respiratory Diseases. Ann Am Thorac Soc 2019;16:657-68. [PMID: 30917290 DOI: 10.1513/AnnalsATS.201812-890CME] [Cited by in Crossref: 15] [Cited by in F6Publishing: 6] [Article Influence: 15.0] [Reference Citation Analysis]
2 Sadiq SA, Shoesmith C. Stem cells in amyotrophic lateral sclerosis: Hype or hope? Neurology 2019;93:1028-9. [PMID: 31740544 DOI: 10.1212/WNL.0000000000008613] [Reference Citation Analysis]
3 Frederiksen HR, Doehn U, Tveden-nyborg P, Freude KK. Non-immunogenic Induced Pluripotent Stem Cells, a Promising Way Forward for Allogenic Transplantations for Neurological Disorders. Front Genome Ed 2021;2:623717. [DOI: 10.3389/fgeed.2020.623717] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
4 Zarzeczny A, Tanner C, Barfoot J, Blackburn C, Couturier A, Munsie M. Contact us for more information: an analysis of public enquiries about stem cells. Regenerative Medicine 2019;14:1137-50. [DOI: 10.2217/rme-2019-0092] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
5 Knoepfler PS. Rapid change of a cohort of 570 unproven stem cell clinics in the USA over 3 years. Regen Med 2019;14:735-40. [PMID: 31456478 DOI: 10.2217/rme-2019-0064] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
6 Plair A, Bennington J, Williams JK, Parker-Autry C, Matthews CA, Badlani G. Regenerative medicine for anal incontinence: a review of regenerative therapies beyond cells. Int Urogynecol J 2021;32:2337-47. [PMID: 33247762 DOI: 10.1007/s00192-020-04620-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Hu W, Zhu S, Fanai ML, Wang J, Cai J, Feng J. 3D co-culture model of endothelial colony-forming cells (ECFCs) reverses late passage adipose-derived stem cell senescence for wound healing. Stem Cell Res Ther 2020;11:355. [PMID: 32795343 DOI: 10.1186/s13287-020-01838-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Abou-El-Enein M, Angelis A, Appelbaum FR, Andrews NC, Bates SE, Bierman AS, Brenner MK, Cavazzana M, Caligiuri MA, Clevers H, Cooke E, Daley GQ, Dzau VJ, Ellis LM, Fineberg HV, Goldstein LSB, Gottschalk S, Hamburg MA, Ingber DE, Kohn DB, Krainer AR, Maus MV, Marks P, Mummery CL, Pettigrew RI, Rutter JL, Teichmann SA, Terzic A, Urnov FD, Williams DA, Wolchok JD, Lawler M, Turtle CJ, Bauer G, Ioannidis JPA. Evidence generation and reproducibility in cell and gene therapy research: A call to action. Mol Ther Methods Clin Dev 2021;22:11-4. [PMID: 34377737 DOI: 10.1016/j.omtm.2021.06.012] [Reference Citation Analysis]
9 Elsallab M, Bravery CA, Kurtz A, Abou-El-Enein M. Mitigating Deficiencies in Evidence during Regulatory Assessments of Advanced Therapies: A Comparative Study with Other Biologicals. Mol Ther Methods Clin Dev 2020;18:269-79. [PMID: 32637456 DOI: 10.1016/j.omtm.2020.05.035] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 9.0] [Reference Citation Analysis]
10 Lindeman A, Pepine CJ, March KL. Cardiac stem cell therapy among Clinics of Uncertain Regulatory Status (COURS): under-regulated, under-observed, incompletely understood. J Transl Med 2020;18:285. [PMID: 32678051 DOI: 10.1186/s12967-020-02425-6] [Reference Citation Analysis]
11 Cuende N, Álvarez-Márquez AJ, Díaz-Aunión C, Castro P, Huet J, Pérez-Villares JM. [The regenerative medicine and stem cell business: confusion with legal implications]. Gac Sanit 2021;35:374-8. [PMID: 32165038 DOI: 10.1016/j.gaceta.2019.12.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
12 Master Z, Matthews KRW, Abou-El-Enein M. Unproven stem cell interventions: A global public health problem requiring global deliberation. Stem Cell Reports 2021;16:1435-45. [PMID: 34107243 DOI: 10.1016/j.stemcr.2021.05.004] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
13 Calinescu AA, Kauss MC, Sultan Z, Al-Holou WN, O'Shea SK. Stem cells for the treatment of glioblastoma: a 20-year perspective. CNS Oncol 2021;10:CNS73. [PMID: 34006134 DOI: 10.2217/cns-2020-0026] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Zarzeczny A. The Future of Stem Cell Research and its Clinical Translation in Canada: Exploring Questions of Governance and Policy Options. Adv Exp Med Biol 2020;1247:1-16. [PMID: 31749135 DOI: 10.1007/5584_2019_450] [Reference Citation Analysis]
15 Ntege EH, Sunami H, Shimizu Y. Advances in regenerative therapy: A review of the literature and future directions. Regen Ther 2020;14:136-53. [PMID: 32110683 DOI: 10.1016/j.reth.2020.01.004] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 20.0] [Reference Citation Analysis]
16 Lyons S, Salgaonkar S, Flaherty GT. International stem cell tourism: a critical literature review and evidence-based recommendations. Int Health 2021:ihab050. [PMID: 34415026 DOI: 10.1093/inthealth/ihab050] [Reference Citation Analysis]
17 Richardson E, Akkas F, Master Z. Evaluating the FDA regenerative medicine framework: opportunities for stakeholders. Regen Med 2020;15:1825-32. [PMID: 32815780 DOI: 10.2217/rme-2020-0073] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
18 Yao D, Ye H, Huo Z, Wu L, Wei S. Mesenchymal stem cell research progress for the treatment of COVID-19. J Int Med Res. 2020;48:300060520955063. [PMID: 32972277 DOI: 10.1177/0300060520955063] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
19 Petkov S, Dressel R, Rodriguez-Polo I, Behr R. Controlling the Switch from Neurogenesis to Pluripotency during Marmoset Monkey Somatic Cell Reprogramming with Self-Replicating mRNAs and Small Molecules. Cells 2020;9:E2422. [PMID: 33167468 DOI: 10.3390/cells9112422] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
20 Sloan EA, Sampognaro PJ, Junn JC, Chin C, Jacques L, Ramachandran PS, DeRisi JL, Wilson MR, Kriegstein AR, Bollen AW, Solomon DA, Margeta M, Engstrom JW. Neuroglial stem cell-derived inflammatory pseudotumor (n-SCIPT): clinicopathologic characterization of a novel lesion of the lumbosacral spinal cord and nerve roots following intrathecal allogeneic stem cell intervention. Acta Neuropathol 2019;138:1103-6. [PMID: 31659431 DOI: 10.1007/s00401-019-02089-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
21 Madhavan AA, Summerfield D, Hunt CH, Kim DK, Krecke KN, Raghunathan A, Benson JC. Polyclonal lymphocytic infiltrate with arachnoiditis resulting from intrathecal stem cell transplantation. Neuroradiol J 2020;33:174-8. [PMID: 32013747 DOI: 10.1177/1971400920902451] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
22 Marcon AR, Allan D, Barber M, Murdoch B, Caulfield T. Portrayal of umbilical cord blood research in the North American popular press: promise or hype? Regen Med 2020;15:1228-37. [PMID: 32101099 DOI: 10.2217/rme-2019-0149] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
23 Wang Y, Qiu T, Liang S, Toumi M. An overview of cell and gene therapy development in China. Hum Gene Ther 2021. [PMID: 34235966 DOI: 10.1089/hum.2021.126] [Reference Citation Analysis]
24 Večerić-Haler Ž, Borštnar Š, Luzar B, Jerše M, Kojc N. Multiorgan failure with fatal outcome after stem cell tourism. Eur J Med Res 2021;26:5. [PMID: 33422096 DOI: 10.1186/s40001-020-00477-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
25 Caulfield T, Murdoch B. Regulatory and policy tools to address unproven stem cell interventions in Canada: the need for action. BMC Med Ethics 2019;20:51. [PMID: 31383026 DOI: 10.1186/s12910-019-0388-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
26 Snyder J, Cohen IG. Medical Crowdfunding for Unproven Medical Treatments: Should Gofundme Become a Gatekeeper? Hastings Center Report 2019;49:32-8. [DOI: 10.1002/hast.1066] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
27 Guilak F, Pferdehirt L, Ross AK, Choi YR, Collins K, Nims RJ, Katz DB, Klimak M, Tabbaa S, Pham CTN. Designer Stem Cells: Genome Engineering and the Next Generation of Cell-Based Therapies. J Orthop Res 2019;37:1287-93. [PMID: 30977548 DOI: 10.1002/jor.24304] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
28 Musial C, Gorska-Ponikowska M. Medical progress: Stem cells as a new therapeutic strategy for COVID-19. Stem Cell Res 2021;52:102239. [PMID: 33601098 DOI: 10.1016/j.scr.2021.102239] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
29 Hwang JC, Staropoli PC, Kuriyan AE, Yannuzzi NA, Sridhar J. Stem Cell Therapy, Ophthalmic Applications, and the Current Controversies With Direct-to-Consumer Marketing. Int Ophthalmol Clin 2020;60:179-92. [PMID: 33093325 DOI: 10.1097/IIO.0000000000000329] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
30 Allan DS. Using umbilical cord blood for regenerative therapy: Proof or promise? Stem Cells 2020;38:590-5. [PMID: 31995251 DOI: 10.1002/stem.3150] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
31 Nair S, Rocha-Ferreira E, Fleiss B, Nijboer CH, Gressens P, Mallard C, Hagberg H. Neuroprotection offered by mesenchymal stem cells in perinatal brain injury: Role of mitochondria, inflammation, and reactive oxygen species. J Neurochem 2021;158:59-73. [PMID: 33314066 DOI: 10.1111/jnc.15267] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
32 Martirosyan NL. Pharmacologic and Cell-Based Therapies for Acute Spinal Cord Injury. Neurosurg Clin N Am 2021;32:389-95. [PMID: 34053726 DOI: 10.1016/j.nec.2021.03.010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
33 Lowry LE, Herzig MC, Christy BA, Schäfer R, Pati S, Cap AP, Bynum JA. Neglected No More: Emerging Cellular Therapies in Traumatic Injury. Stem Cell Rev Rep 2021;17:1194-214. [PMID: 33420590 DOI: 10.1007/s12015-020-10086-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
34 Glassberg MK, Csete I, Simonet E, Elliot SJ. Stem Cell Therapy for COPD: Hope and Exploitation. Chest 2021:S0012-3692(21)00709-1. [PMID: 33894254 DOI: 10.1016/j.chest.2021.04.020] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
35 Tanner C, Munsie M, Sipp D, Turner L, Wheatland C. The politics of evidence in online illness narratives: An analysis of crowdfunding for purported stem cell treatments. Health (London) 2019;23:436-57. [DOI: 10.1177/1363459319829194] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
36 Ghinea N, Munsie M, Rudge C, Stewart C. Australian regulation of autologous human cell and tissue products: implications for commercial stem cell clinics. Regenerative Medicine 2020;15:1361-9. [DOI: 10.2217/rme-2019-0124] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
37 Smith C, Crowley A, Munsie M, Behfar A, DeMartino ES, Staff NP, Shapiro SA, Master Z. Academic Physician Specialists' Approaches to Counseling Patients Interested in Unproven Stem Cell and Regenerative Therapies-A Qualitative Analysis. Mayo Clin Proc 2021:S0025-6196(21)00599-1. [PMID: 34454715 DOI: 10.1016/j.mayocp.2021.06.026] [Reference Citation Analysis]
38 Turner L, Munsie M, Levine AD, Ikonomou L. Ethical issues and public communication in the development of cell-based treatments for COVID-19: Lessons from the pandemic. Stem Cell Reports 2021;16:2567-76. [PMID: 34653406 DOI: 10.1016/j.stemcr.2021.09.005] [Reference Citation Analysis]
39 Mah N, Seltmann S, Aran B, Steeg R, Dewender J, Bultjer N, Veiga A, Stacey GN, Kurtz A. Access to stem cell data and registration of pluripotent cell lines: The Human Pluripotent Stem Cell Registry (hPSCreg). Stem Cell Research 2020;47:101887. [DOI: 10.1016/j.scr.2020.101887] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
40 Hawke B, Przybylo AR, Paciulli D, Caulfield T, Zarzeczny A, Master Z. How to Peddle Hope: An Analysis of YouTube Patient Testimonials of Unproven Stem Cell Treatments. Stem Cell Reports 2019;12:1186-9. [PMID: 31189092 DOI: 10.1016/j.stemcr.2019.05.009] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 20.0] [Reference Citation Analysis]
41 Rahangdale R, Rana S, Prakash P, Ali M, Flaherty M, Synowiec A, Baser S, Scott T. Glioneuronal Growth Infiltrating Lumbosacral Nerve Roots Following Intrathecal Stem Cell Injections Highlighting Perils of Stem Cell Tourism. Mov Disord Clin Pract 2019;6:324-6. [PMID: 31061842 DOI: 10.1002/mdc3.12741] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
42 Mukherjee S, Yadav G, Kumar R. Recent trends in stem cell-based therapies and applications of artificial intelligence in regenerative medicine. World J Stem Cells 2021; 13(6): 521-541 [PMID: 34249226 DOI: 10.4252/wjsc.v13.i6.521] [Reference Citation Analysis]
43 Goddard NV, Waterhouse N. Regenerative Medicine, Stem Cell Therapies, and Platelet-Rich Plasma: Where Is the Evidence? Aesthet Surg J 2020;40:460-5. [PMID: 31930387 DOI: 10.1093/asj/sjz317] [Reference Citation Analysis]
44 Woodworth CF, Jenkins G, Barron J, Hache N. Intramedullary cervical spinal mass after stem cell transplantation using an olfactory mucosal cell autograft. CMAJ. 2019;191:E761-E764. [PMID: 31285379 DOI: 10.1503/cmaj.181696] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 10.0] [Reference Citation Analysis]
45 Amadeo F, Trivino Cepeda K, Littlewood J, Wilm B, Taylor A, Murray P. Mesenchymal stromal cells: what have we learned so far about their therapeutic potential and mechanisms of action? Emerg Top Life Sci 2021;5:549-62. [PMID: 34495324 DOI: 10.1042/ETLS20210013] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
46 Caplan H, Olson SD, Kumar A, George M, Prabhakara KS, Wenzel P, Bedi S, Toledano-Furman NE, Triolo F, Kamhieh-Milz J, Moll G, Cox CS Jr. Mesenchymal Stromal Cell Therapeutic Delivery: Translational Challenges to Clinical Application. Front Immunol 2019;10:1645. [PMID: 31417542 DOI: 10.3389/fimmu.2019.01645] [Cited by in Crossref: 84] [Cited by in F6Publishing: 83] [Article Influence: 42.0] [Reference Citation Analysis]
47 Rudge C, Ghinea N, Munsie M, Stewart C. Regulating autologous stem cell interventions in Australia: updated review of the direct-to-consumer advertising restrictions. Aust Health Rev 2021;45:507-15. [PMID: 33952390 DOI: 10.1071/AH20217] [Reference Citation Analysis]
48 Smith C, Martin-Lillie C, Higano JD, Turner L, Phu S, Arthurs J, Nelson TJ, Shapiro S, Master Z. Challenging misinformation and engaging patients: characterizing a regenerative medicine consult service. Regen Med 2020;15:1427-40. [PMID: 32319855 DOI: 10.2217/rme-2020-0018] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
49 Cuende N, Álvarez-Márquez AJ, Díaz-Aunión C, Castro P, Huet J, Pérez-Villares JM. Promoting the ethical use of safe and effective cell-based products: the Andalusian plan on regenerative medicine. Cytotherapy 2020;22:712-7. [PMID: 32878735 DOI: 10.1016/j.jcyt.2020.07.007] [Reference Citation Analysis]
50 Piuzzi NS, Emara A, Chahla J, Mandelbaum BR. Ethical and Practical Considerations for Integrating Cellular ("Stem Cell") Therapy into Clinical Practice. Curr Rev Musculoskelet Med 2020;13:525-9. [PMID: 32468421 DOI: 10.1007/s12178-020-09647-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
51 Lomax GP, Torres A, Millan MT. Regulated, reliable, and reputable: Protect patients with uniform standards for stem cell treatments. Stem Cells Transl Med 2020;9:547-53. [PMID: 32040254 DOI: 10.1002/sctm.19-0377] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
52 Rezak M, de Carvalho M. Disease modification in neurodegenerative diseases: Not quite there yet. Neurology 2019;94:12-3. [DOI: 10.1212/wnl.0000000000008690] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
53 Price J. Cell therapy approaches to autism: a review of clinical trial data. Mol Autism 2020;11:37. [PMID: 32448347 DOI: 10.1186/s13229-020-00348-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
54 Wagner DE, Ikonomou L, Gilpin SE, Magin CM, Cruz F, Greaney A, Magnusson M, Chen YW, Davis B, Vanuytsel K, Rolandsson Enes S, Krasnodembskaya A, Lehmann M, Westergren-Thorsson G, Stegmayr J, Alsafadi HN, Hoffman ET, Weiss DJ, Ryan AL. Stem Cells, Cell Therapies, and Bioengineering in Lung Biology and Disease 2019. ERJ Open Res 2020;6:00123-2020. [PMID: 33123557 DOI: 10.1183/23120541.00123-2020] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
55 Yeo-Teh NSL, Tang BL. Moral obligations in conducting stem cell-based therapy trials for autism spectrum disorder. J Med Ethics 2021:medethics-2020-107106. [PMID: 33858947 DOI: 10.1136/medethics-2020-107106] [Reference Citation Analysis]
56 Hashemian SR, Aliannejad R, Zarrabi M, Soleimani M, Vosough M, Hosseini SE, Hossieni H, Keshel SH, Naderpour Z, Hajizadeh-Saffar E, Shajareh E, Jamaati H, Soufi-Zomorrod M, Khavandgar N, Alemi H, Karimi A, Pak N, Rouzbahani NH, Nouri M, Sorouri M, Kashani L, Madani H, Aghdami N, Vasei M, Baharvand H. Mesenchymal stem cells derived from perinatal tissues for treatment of critically ill COVID-19-induced ARDS patients: a case series. Stem Cell Res Ther 2021;12:91. [PMID: 33514427 DOI: 10.1186/s13287-021-02165-4] [Cited by in Crossref: 21] [Cited by in F6Publishing: 29] [Article Influence: 21.0] [Reference Citation Analysis]
57 Zhao PY, Ji S, Newman-Casey PA, Andrews CA, Lonardi A, Bennett OM, Dinh DQ, Talwar N, Hutton DW, Temple S, Stern JH, Rao RC. Assessing patient perception of risk in ocular stem cell therapies. Stem Cell Reports 2021;16:2415-21. [PMID: 34597599 DOI: 10.1016/j.stemcr.2021.09.001] [Reference Citation Analysis]
58 Gentile P, Sterodimas A, Pizzicannella J, Calabrese C, Garcovich S. Research progress on Mesenchymal Stem Cells (MSCs), Adipose-Derived Mesenchymal Stem Cells (AD-MSCs), Drugs, and Vaccines in Inhibiting COVID-19 Disease. Aging Dis 2020;11:1191-201. [PMID: 33014532 DOI: 10.14336/AD.2020.0711] [Cited by in Crossref: 17] [Cited by in F6Publishing: 10] [Article Influence: 17.0] [Reference Citation Analysis]
59 Snyder J, Turner L. Crowdfunding for stem cell-based interventions to treat neurologic diseases and injuries. Neurology 2019;93:252-8. [DOI: 10.1212/wnl.0000000000007838] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
60 Kurtz A, Elsallab M, Sanzenbacher R, Abou-el-enein M. Linking Scattered Stem Cell-Based Data to Advance Therapeutic Development. Trends in Molecular Medicine 2019;25:8-19. [DOI: 10.1016/j.molmed.2018.10.008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
61 Fu W, Smith C, Turner L, Fojtik J, Pacyna JE, Master Z. Characteristics and Scope of Training of Clinicians Participating in the US Direct-to-Consumer Marketplace for Unproven Stem Cell Interventions. JAMA 2019;321:2463-4. [PMID: 31237628 DOI: 10.1001/jama.2019.5837] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
62 Waldby C, Hendl T, Kerridge I, Lipworth W, Lysaght T, Munsie M, Stewart C. The direct-to-consumer market for stem cell-based interventions in Australia: exploring the experiences of patients. Regenerative Medicine 2020;15:1238-49. [DOI: 10.2217/rme-2019-0089] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
63 Zhang B, Napoleon JV, Liu X, Luo Q, Srinivasarao M, Low PS. Sensitive manipulation of CAR T cell activity using a chimeric endocytosing receptor. J Immunother Cancer 2020;8:e000756. [PMID: 33127654 DOI: 10.1136/jitc-2020-000756] [Reference Citation Analysis]
64 Rodriguez HC, Gupta M, Cavazos-Escobar E, El-Amin SF 3rd, Gupta A. Umbilical cord: an allogenic tissue for potential treatment of COVID-19. Hum Cell 2021;34:1-13. [PMID: 33033884 DOI: 10.1007/s13577-020-00444-5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
65 Pluchino S, Smith JA, Peruzzotti-Jametti L. Promises and Limitations of Neural Stem Cell Therapies for Progressive Multiple Sclerosis. Trends Mol Med 2020;26:898-912. [PMID: 32448751 DOI: 10.1016/j.molmed.2020.04.005] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 14.0] [Reference Citation Analysis]
66 Smith C, Crowley A, Munsie M, DeMartino ES, Staff NP, Shapiro S, Master Z. Academic physician specialists' views toward the unproven stem cell intervention industry: areas of common ground and divergence. Cytotherapy 2021;23:348-56. [PMID: 33563545 DOI: 10.1016/j.jcyt.2020.12.011] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]